Arrhenoblastoma of ovary; Gonadal stromal tumor; Sex cord tumor; Androblastoma
Arrhenoblastoma of the ovary is an ovarian tumor that secretes testosterone.
Causes, incidence, and risk factors
This is a rare tumor that accounts for less than 0.5% of all ovarian tumors. These tumors are found in women of all age groups, but are most common in young women.
This tumor secretes male hormones which causes secondary sex changes in women including:
- deepening of the voice
- increased facial and body hair
- increased size of the clitoris
- male pattern baldness
Signs and tests
- ultrasound of the ovaries
- CT scan of pelvis and abdomen to look for tumor spread
- blood tests to check levels of hormones which may be secreted by the tumor
Surgery is the main treatment. If the cancer has spread, chemotherapy or radiation therapy should be considered.
The stress of illness can often be helped by joining a support group where members share common experiences and problems. See cancer - support group.
The outcome of this disease depends on the extent of disease and the ability to completely remove the tumor with surgery. The overall 5-year survival rate is around 70-90%.
Fortunately, arrhenoblastoma has a low chance of spreading (metastasis). If the tumor is detected early, the cure rate may be very good.
- Masculinization as described above.
- Surgical complications depending on the extent of surgery.
- Spread of the tumor if it is not completely removed.
Calling your health care provider
Call your health care provider if you are a woman experiencing signs of masculinization or if you feel a mass near your ovaries.
There is no good screening test. Annual gynecological exams and early recognition of signs of masculinization are important in the detection of the disease.
by Simon D. Mitin, M.D.
All ArmMed Media material is provided for information only and is neither advice nor a substitute for proper medical care. Consult a qualified healthcare professional who understands your particular history for individual concerns.